Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3051% below fair value
$44.34+0.14 (+0.32%)
Close on Nov 13, 2026Market cap $64.26BP/E 18.8Yield –
Boston Scientific price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Boston Scientific's price to sales ratio was 3.2× on Nov 11, 2026, against 7.8× a year earlier. Over the last 5 years it ranged from 3.0× to 9.5×, with a median of 5.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.2× | −4.2 |
| 2025 | Dec 31, 2025 | 7.4× | −1.0 |
| 2024 | Dec 31, 2024 | 8.3× | +2.2 |
| 2023 | Dec 29, 2023 | 6.1× | +0.8 |
| 2022 | Dec 30, 2022 | 5.3× | −0.0 |
| 2021 | Dec 31, 2021 | 5.3× | +0.3 |
| 2020 | Dec 31, 2020 | 5.0× | −1.0 |
| 2019 | Dec 31, 2019 | 6.1× | +1.0 |
| 2018 | Dec 31, 2018 | 5.1× | +1.2 |
| 2017 | Dec 29, 2017 | 3.9× | +0.1 |
| 2016 | Dec 30, 2016 | 3.8× | +0.5 |
| 2015 | Dec 31, 2015 | 3.3× | +0.9 |
| 2014 | Dec 31, 2014 | 2.4× | +0.0 |
| 2013 | Dec 31, 2013 | 2.4× | +1.3 |
| 2012 | Dec 31, 2012 | 1.1× | +0.1 |
| 2011 | Dec 30, 2011 | 1.0× | −0.4 |
| 2010 | Dec 31, 2010 | 1.5× | −0.2 |
| 2009 | Dec 31, 2009 | 1.7× | – |
See a number that looks wrong?